The storied success of sildenafil has undeniably influenced the pharmaceutical landscape. However, investing in companies heavily focused on biosimilars and the diminishing patent rights surrounding this https://socialaffluent.com/story6996913/sildenafil-and-pharma-a-risky-opportunity